Lyell Immunopharma, Inc. (LYEL)
NASDAQ: LYEL · Real-Time Price · USD
0.613
-0.028 (-4.42%)
Dec 20, 2024, 4:00 PM EST - Market closed
Lyell Immunopharma Market Cap
Lyell Immunopharma has a market cap or net worth of $171.08 million as of December 20, 2024. Its market cap has decreased by -64.99% in one year.
Market Cap
171.08M
Enterprise Value
-231.01M
1-Year Change
-64.99%
Ranking
Category
Stock Price
$0.61
Market Cap Chart
Since the IPO on June 17, 2021, Lyell Immunopharma's market cap has decreased from $4.13B to $171.08M, a decrease of -95.86%. That is a compound annual growth rate of -59.60%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 20, 2024 | 171.08M | -64.99% |
| Dec 29, 2023 | 488.63M | -43.52% |
| Dec 30, 2022 | 865.16M | -53.52% |
| Dec 31, 2021 | 1.86B | -54.91% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Organigram Holdings | 183.68M |
| Orchestra BioMed Holdings | 182.46M |
| Genfit | 181.18M |
| Inozyme Pharma | 180.51M |
| Accuray | 180.01M |
| Profound Medical | 175.78M |
| EUDA Health Holdings | 175.50M |
| Alector | 174.32M |